✦ LIBER ✦

P-7 Docetaxel as second-line chemotherapy (CT) in advanced non small cell lung cancer(NSCLC) patients (pts): does it really work?

✍ Scribed by Barradas, Pedro S.; Oliveira, Ana S.; Costa, Agostino S.; Figueiredo, Ana M.; Alves, Ana P.; Cristovao, Margarida M.; Barata, Fernando J.; Melo, Maria-Jose S.

Book ID: 118571708
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 183 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91976-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly docetaxel as second line chemothe

Weekly docetaxel as second line chemotherapy in advanced non small cell lung cancer (NSCLC): Final results and survival analysis

✍ M. Serke; D. Argiropolus; N. Schönfeld; R. Loddenkemper 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

P-17 Docetaxel and carboplatin as a seco

P-17 Docetaxel and carboplatin as a second line chemotherapy in advanced non-small cell lung cancer

✍ Hatabay, Nilgün; Ece, Ferah 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Phase II study of docetaxel (DOC) and ca

Phase II study of docetaxel (DOC) and carboplatin (CP) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Second-line treatment with single-agent

Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

P-462 French practitioner survey on seco

P-462 French practitioner survey on second line chemotherapy (CT) forpatients (pts) with advanced non-small cell lung cancer (NSCLC) after first-line treatment with docetaxel and cisplatin (TXT-CDDP): Preliminary results

✍ Breton, J.; Robinet, G.; Dansin, E.; Le Groumellec, A.; Dourthe, L.; Payrard, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

P-551 Single-agent navelbine oral (NVBo)

P-551 Single-agent navelbine oral (NVBo) as chemotherapy (CT) in elderly patients (pts) with advanced stage or metastatic non-small cell lung cancer (NSCLC)

✍ Parente, B.; Queiroga, H.; Espanhol, V.; Cunha, J.; Fernandes, A.; Barroso, A.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 272 KB